GlassScriptPhysician profile
Ann Hu
NPI 1265061022
$659.55
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $247 · 2023: $384 · 2024: $28.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.33 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $88.12 | 2022-2023 | Farxiga |
| Organon LLC | $80.42 | 2023 | Nexplanon |
| Glaxosmithkline, LLC. | $78.51 | 2022-2023 | Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $65.55 | 2022-2023 | Rexulti |
| Abbvie INC. | $59.96 | 2022-2024 | |
| Lilly USA, LLC | $56.08 | 2022-2023 | Mounjaro |
| Novo Nordisk INC | $46.86 | 2022-2023 | Rybelsus, Ozempic |
| Idorsia Pharmaceuticals US INC | $42.32 | 2022-2023 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.25 | 2022-2023 | Xifaxan, Trulance |
| Pfizer INC. | $22.47 | 2023 | |
| Ironwood Pharmaceuticals, INC | $20.52 | 2023 | Linzess |
| Exact Sciences Corporation | $17.96 | 2023 | Cologuard Collection Kit |
| Currax Pharmaceuticals LLC | $16.24 | 2023 | Contrave |
| Amgen INC. | $13.89 | 2023 | |
| Shield Therapeutics INC | $13.40 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.